EQS-Adhoc: MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
|
EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
31-Jul-2023 / 16:27 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Bremen, July 31, 2023 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its annual forecast for the current fiscal year based on the preliminary business figures for the first ten months.
In light of a challenging macroeconomic environment with accelerating inflation and the ongoing war in Ukraine, MeVis Medical Solutions AG sees its revenue performance more cautious than before due to current project developments and subdued expectations in new projects. For fiscal year 2022/2023 (October 1, 2022 to September 30, 2023), revenues are now expected to decline to between € 17.0 million and € 17.5 million (previous forecast: stable revenues of € 18.0 million to € 18.5 million). EBIT (earnings before interest and taxes) is expected to be in a range of € 3.5 million to € 4.0 million in fiscal 2022/2023 in view of the changed assumptions (previous forecast: decline to € 4.5 million to € 5.0 million). In addition, earnings have been strongly impacted by the development of the US dollar/euro exchange rate since the beginning of the fiscal year.
Contact:
Kirchhoff, Marcus / CEO
End of Inside Information
31-Jul-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
MeVis Medical Solutions AG |
|
Caroline-Herschel-Str. 1 |
|
28359 Bremen |
|
Germany |
| Phone: |
+49 421 224 95 0 |
| Fax: |
+49 421 224 95 999 |
| E-mail: |
[email protected] |
| Internet: |
http://www.mevis.de |
| ISIN: |
DE000A0LBFE4 |
| WKN: |
A0LBFE |
| Listed: |
Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1692327 |
| |
| End of Announcement |
EQS News Service |
1692327 31-Jul-2023 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
18,54 |
16,76 |
18,07 |
17,13 |
16,21 |
18,76 |
17,34 |
| EBITDA1,2 |
9,18 |
7,60 |
8,25 |
5,97 |
4,77 |
7,99 |
3,99 |
| EBITDA-Marge3 |
49,51 |
45,35 |
45,66 |
34,85 |
29,43 |
42,59 |
|
| EBIT1,4 |
7,96 |
6,69 |
8,00 |
5,81 |
4,64 |
7,90 |
3,89 |
| EBIT-Marge5 |
42,93 |
39,92 |
44,27 |
33,92 |
28,62 |
42,11 |
22,43 |
| Jahresüberschuss1 |
5,62 |
7,17 |
8,07 |
5,70 |
4,55 |
7,79 |
4,92 |
| Netto-Marge6 |
30,31 |
42,78 |
44,66 |
33,27 |
28,07 |
41,52 |
28,37 |
| Cashflow1,7 |
7,32 |
5,52 |
6,55 |
2,89 |
9,13 |
4,86 |
5,85 |
| Ergebnis je Aktie8 |
3,09 |
3,94 |
4,43 |
3,13 |
2,50 |
4,28 |
2,70 |
| Dividende8 |
0,95 |
0,95 |
0,95 |
0,95 |
0,95 |
0,95 |
0,95 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Deloitte
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| MeVis Med. Solutions |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A0LBFE |
25,800 |
Halten |
46,96 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 10,75 |
10,28 |
1,05 |
7,86 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 2,63 |
8,02 |
2,71 |
10,98 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,95 |
0,95 |
3,68 |
19.03.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| - |
27.05.2024 |
- |
29.01.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 3,78% |
-3,51% |
2,38% |
-18,87% |
|
|
MeVis Medical Solutions AG DE000A0LBFE4